In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms

Show simple item record

dc.contributor.author Field, Des
dc.contributor.author O'Connor, Rory
dc.contributor.author Cotter, Paul D.
dc.contributor.author Ross, R. Paul
dc.contributor.author Hill, Colin
dc.date.accessioned 2017-06-20T11:39:46Z
dc.date.available 2017-06-20T11:39:46Z
dc.date.issued 2016-04-18
dc.identifier.citation Field, D., O’ Connor, R., Cotter, P. D., Ross, R. P. and Hill, C. (2016) 'In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms', Frontiers in Microbiology, 7, 508 (11pp). doi: 10.3389/fmicb.2016.00508 en
dc.identifier.volume 7
dc.identifier.startpage 1
dc.identifier.endpage 11
dc.identifier.issn 1664-302X
dc.identifier.uri http://hdl.handle.net/10468/4113
dc.identifier.doi 10.3389/fmicb.2016.00508
dc.description.abstract The development and spread of pathogenic bacteria that are resistant to the existing catalogue of antibiotics is a major public health threat. Biofilms are complex, sessile communities of bacteria embedded in an organic polymer matrix which serve to further enhance antimicrobial resistance. Consequently, novel compounds and innovative methods are urgently required to arrest the proliferation of drug-resistant infections in both nosocomial and community environments. Accordingly, it has been suggested that antimicrobial peptides could be used as novel natural inhibitors that can be used in formulations with synergistically-acting antibiotics. Nisin is a member of the lantibiotic family of antimicrobial peptides that exhibit potent antibacterial activity against many Gram-positive bacteria. Recently we have used bioengineering strategies to enhance the activity of nisin against several high profile targets, including multi-drug resistant clinical pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), staphylococci and streptococci associated with bovine mastitis. We have also identified nisin derivatives with an enhanced ability to impair biofilm formation and to reduce the density of established biofilms of methicillin resistant Staphylococcus pseudintermedius (MRSP). The present study was aimed at evaluating the potential of nisin and nisin derivatives to increase the efficacy of conventional antibiotics and to assess the possibility of killing and/or eradicating biofilm-associated cells of a variety of staphylococcal targets. Growth curve-based comparisons established that combinations of derivatives nisin V + penicillin or nisin I4V + chloramphenicol had an enhanced inhibitory effect against S. aureus SA113 and S. pseudintermedius DSM21284 respectively compared to the equivalent nisin A + antibiotic combinations or when each antimicrobial was administered alone. Furthermore, the metabolic activity of established biofilms treated with nisin V + chloramphenicol and nisin I4V + chloramphenicol combinations revealed a significant decrease in S. aureus SA113 and S. pseudintermedius DSM21284 biofilm viability respectively compared to the nisin A + antibiotic combinations as determined by the rapid colorimetric XTT assay. The results indicate that the activities of the nisin derivative and antibiotic combinations represent a significant improvement over that of the wild-type nisin and antibiotic combination and merit further investigation with a view to their use as anti-biofilm agents. en
dc.description.sponsorship Science Foundation Ireland(Technology and Innovation Development Award (TIDA 14/TIDA/2286), SFI Investigator awards (10/IN.1/B3027), SFI-PI funding (11/PI/1137) Grant Number SFI/12/RC/2273); Irish Government (National Development Plan) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Frontiers Media en
dc.relation.uri http://journal.frontiersin.org/article/10.3389/fmicb.2016.00508/full
dc.rights © 2016, Field, O’ Connor, Cotter, Ross and Hill. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. en
dc.rights.uri https://creativecommons.org/licenses/by/4.0/ en
dc.subject Biofilm en
dc.subject Bacterial resistance en
dc.subject Antimicrobial peptide en
dc.subject Nisin en
dc.subject Lantibiotic en
dc.subject Bacteriocin en
dc.subject Staphylococci en
dc.subject Antibiotics en
dc.title In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Des Field, Microbiology, University College Cork, Cork, Ireland +353-21-490-3000 E-mail: des.field@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.contributor.funder Science Foundation Ireland en
dc.contributor.funder Irish Government en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Frontiers in Microbiology en
dc.internal.IRISemailaddress des.field@ucc.ie en
dc.identifier.articleid 508


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2016, Field, O’ Connor, Cotter, Ross and Hill. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Except where otherwise noted, this item's license is described as © 2016, Field, O’ Connor, Cotter, Ross and Hill. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement